Literature DB >> 10708593

cDNA cloning of an alternative splicing variant of protein kinase C delta (PKC deltaIII), a new truncated form of PKCdelta, in rats.

T Ueyama1, Y Ren, S Ohmori, K Sakai, N Tamaki, N Saito.   

Abstract

Recently, an alternative splicing variant of mouse protein kinase C delta (PKC deltaII, GenBank Accession No. AB011812) has been reported which has a 78 bp (26 amino acid) insertion at the caspase-3 recognition sequence in the V3 region of PKC delta (PKC deltaI). We isolated a cDNA encoding a new variant of PKC delta (PKC deltaIII, AF219629), which has a 83 bp insertion at the same site in the V3 region, by RT-PCR using rat testis RNA as a template. In rats, the 83 bp insertion causes inframe termination, and rat PKC deltaIII protein is expressed as a truncated form, having only the regulatory domain without a catalytic domain. Genomic DNA analysis revealed that the difference between mouse PKC deltaII and rat PKC deltaIII is derived from the different sequence at the 5'-splicing donor sites. To investigate the potential functions of the truncated form of PKC delta, rat PKC deltaIII fused to green fluorescent protein (GFP) was expressed in CHO-K1 cells. PKC deltaIII-GFP was localized in the cytoplasm with dot-like accumulation and highly expressed on the plasma membrane, whereas PKC deltaI-GFP is localized homogeneously throughout the cytoplasm, including the nucleoplasm. Stimulation by phorbol ester caused weak translocation of deltaIII-GFP from the cytosol to the plasma membrane. These results suggest that PKC deltaIII may show a dominant negative effect against PKC deltaI, and that the modulation of signal transduction by alternative splicing variant may play a crucial role in the physiological and/or pathological conditions, and the pathogenesis of disease. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708593     DOI: 10.1006/bbrc.2000.2331

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  PKCdelta alternatively spliced isoforms modulate cellular apoptosis in retinoic acid-induced differentiation of human NT2 cells and mouse embryonic stem cells.

Authors:  Niketa A Patel; Shijie S Song; Denise R Cooper
Journal:  Gene Expr       Date:  2006

Review 2.  Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

Authors:  Sanford R Sampson; Denise R Cooper
Journal:  Mol Genet Metab       Date:  2006-06-23       Impact factor: 4.797

3.  Multi-level regulation of PKCδI alternative splicing by lithium chloride.

Authors:  Deena Bader; Rekha S Patel; Ashley Lui; Chetna Thawani; Rea Rupani; Gitanjali Vidyarthi; Niketa A Patel
Journal:  Mol Cell Biol       Date:  2020-12-07       Impact factor: 4.272

4.  Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.

Authors:  Hercules Apostolatos; André Apostolatos; Timothy Vickers; James E Watson; Shijie Song; Fernando Vale; Denise R Cooper; Juan Sanchez-Ramos; Niketa A Patel
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

5.  Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism.

Authors:  François Renault-Mihara; Frédéric Beuvon; Xavier Iturrioz; Brigitte Canton; Sophie De Bouard; Nadine Léonard; Shahul Mouhamad; Ariane Sharif; Joe W Ramos; Marie-Pierre Junier; Hervé Chneiweiss
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

Review 6.  Protein kinase C pharmacology: refining the toolbox.

Authors:  Alyssa X Wu-Zhang; Alexandra C Newton
Journal:  Biochem J       Date:  2013-06-01       Impact factor: 3.857

7.  Molecular genetics and structural genomics of the human protein kinase C gene module.

Authors:  Kurt Kofler; Martin Erdel; Gerd Utermann; Gottfried Baier
Journal:  Genome Biol       Date:  2002-02-27       Impact factor: 13.583

Review 8.  Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective.

Authors:  Li-Na Miao; Deng Pan; Junhe Shi; Jian-Peng Du; Peng-Fei Chen; Jie Gao; Yanqiao Yu; Da-Zhuo Shi; Ming Guo
Journal:  Front Cardiovasc Med       Date:  2022-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.